The Procter & Gamble Company (ETR:PRG)

Sage Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	305,579	318,063	363,272	327,604	330,022	278,609
Market Cap Growth	-12.45%	-12.45%	10.89%	-0.73%	18.45%	5.92%
Enterprise Value	327,190	340,269	387,752	355,174	355,140	296,333
Last Close Price	130.94	134.22	150.22	130.78	125.35	102.05
PE Ratio	22.47	23.38	26.67	24.89	23.86	23.54
PS Ratio	4.26	4.43	4.63	4.36	4.30	4.34
PB Ratio	6.86	7.14	7.70	7.60	7.36	7.08
P/FCF Ratio	-	26.60	23.56	25.94	25.43	21.20
P/OCF Ratio	-	20.97	19.61	21.23	20.63	17.98
EV/Sales Ratio	4.48	4.74	4.94	4.73	4.63	4.62
EV/EBITDA Ratio	16.21	17.15	17.42	17.81	17.47	16.56
EV/EBIT Ratio	18.47	19.54	19.83	20.35	20.13	19.01
EV/FCF Ratio	27.36	28.45	25.14	28.13	27.36	22.55
Debt / Equity Ratio	0.66	0.66	0.67	0.78	0.69	0.70
Debt / EBITDA Ratio	1.48	1.48	1.39	1.65	1.50	1.52
Debt / FCF Ratio	2.46	2.46	2.04	2.65	2.38	2.11
Asset Turnover	0.68	0.68	0.69	0.69	0.68	0.63
Inventory Turnover	5.65	5.65	5.76	6.09	6.53	6.46
Quick Ratio	0.44	0.44	0.46	0.38	0.37	0.45
Current Ratio	0.70	0.70	0.74	0.63	0.66	0.70
Return on Equity (ROE)	31.24%	31.24%	30.68%	31.38%	31.64%	30.69%
Return on Assets (ROA)	10.33%	10.33%	10.77%	10.01%	9.75%	9.63%
Return on Capital (ROIC)	14.95%	14.95%	15.60%	14.64%	14.53%	14.26%
Return on Capital Employed (ROCE)	22.90%	22.90%	23.60%	22.40%	21.90%	21.40%
Earnings Yield	4.45%	4.28%	3.82%	4.10%	4.27%	4.33%
FCF Yield	3.91%	3.76%	4.25%	3.85%	3.93%	4.72%
Dividend Yield	2.85%	2.59%	2.38%	2.58%	2.69%	2.68%
Payout Ratio	61.80%	61.80%	62.59%	61.41%	59.49%	57.76%
Buyback Yield / Dilution	0.71%	0.71%	0.48%	2.17%	2.38%	0.94%
Total Shareholder Return	3.56%	3.29%	2.86%	4.75%	5.07%	3.62%

Updated Jan 22, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.